Although antigen-primed CD62LintCD44high (III) cells gave rise to tumor infiltrating CD62L+ and CD62L- cells, CD62Llow CD44high (IV) cells in tumor-draining lymph nodes could be a major source of highly activated CD8 T cells, which kill tumor cells. The gene discussed is CD8A; the disease is neoplasm.